A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Bimatoprost
Orvepitant
The risk or severity of adverse effects can be increased when Orvepitant is combined with Acenocoumarol.
Bimatoprost
Esreboxetine
The risk or severity of adverse effects can be increased when Esreboxetine is combined with Acenocoumarol.
Bimatoprost
Piclozotan
The risk or severity of adverse effects can be increased when Piclozotan is combined with Acenocoumarol.
Bimatoprost
Cerlapirdine
The risk or severity of adverse effects can be increased when Cerlapirdine is combined with Acenocoumarol.
Bimatoprost
Gepirone
The risk or severity of adverse effects can be increased when Gepirone is combined with Acenocoumarol.
Bimatoprost
Eplivanserin
The risk or severity of adverse effects can be increased when Eplivanserin is combined with Acenocoumarol.
Bimatoprost
MK-212
The risk or severity of adverse effects can be increased when MK-212 is combined with Acenocoumarol.
Bimatoprost
m-Chlorophenylpiperazine
The risk or severity of adverse effects can be increased when m-Chlorophenylpiperazine is combined with Acenocoumarol.
Bimatoprost
Vabicaserin
The risk or severity of adverse effects can be increased when Vabicaserin is combined with Acenocoumarol.
Bimatoprost
Idalopirdine
The risk or severity of adverse effects can be increased when Idalopirdine is combined with Acenocoumarol.
Bimatoprost
Lanicemine
The risk or severity of adverse effects can be increased when Lanicemine is combined with Acenocoumarol.
Bimatoprost
Tetrahydrocannabivarin
The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Acenocoumarol.
Bimatoprost
Tropisetron
The risk or severity of adverse effects can be increased when Tropisetron is combined with Acenocoumarol.
Bimatoprost
Iferanserin
The risk or severity of adverse effects can be increased when Iferanserin is combined with Acenocoumarol.
Bimatoprost
Mosapride
The risk or severity of adverse effects can be increased when Mosapride is combined with Acenocoumarol.
Bimatoprost
Oxaprotiline
The risk or severity of adverse effects can be increased when Oxaprotiline is combined with Acenocoumarol.
Bimatoprost
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Acenocoumarol.
Bimatoprost
Iproclozide
The risk or severity of adverse effects can be increased when Iproclozide is combined with Acenocoumarol.
Bimatoprost
Brilaroxazine
The risk or severity of adverse effects can be increased when Brilaroxazine is combined with Acenocoumarol.
Bimatoprost
Etoperidone
The risk or severity of adverse effects can be increased when Etoperidone is combined with Acenocoumarol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3